Plant Comparison
Hawthorn vs Fenugreek
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Hawthorn and Fenugreek: they share 5 indicated uses (arthritis / joint pain, cancer (anticancer research), cardiovascular / heart health, …); 2 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Hawthorn | Fenugreek | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 1/10 | 8/10 | Stronger for Fenugreek |
| Cancer (anticancer research) | 2/10 | 7/10 | Stronger for Fenugreek |
| Cardiovascular / heart health | 1/10 | 7/10 | Stronger for Fenugreek |
| Inflammation (general) | 1/10 | 7/10 | Stronger for Fenugreek |
| Skin irritation | 1/10 | 7/10 | Stronger for Fenugreek |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
Principal cardioprotective and antioxidant polyphenols characterised by chemical profiling of leaf, flower and fruit.
Contribute to the vasoactive and antioxidant effects, the basis for extract standardisation.
Thought to contribute to the antidiabetic and cholesterol-lowering effects.
Mucilaginous soluble fiber that slows carbohydrate absorption, a key mechanism behind the blood-sugar-lowering effect.
An unusual amino acid studied for insulin-potentiating activity.
Aromatic lactone responsible for fenugreek's characteristic maple-syrup smell, including the body-odor effect reported with supplementation.
Pharmacological Actions
Traditional & Indicated Uses
inferred from anti-inflammatory action
inferred from anticancer action
inferred from anti-inflammatory action
inferred from sedative action
inferred from anti-inflammatory action
inferred from antidiabetic action
inferred from anticancer action
inferred from anti-inflammatory action
Safety, Cautions & Contraindications
Generally well tolerated. Hawthorn should not replace prescribed cardiac medications without medical supervision. May potentiate the effects of cardiac glycosides (digoxin), antihypertensive drugs, and coronary dilators. Not recommended during pregnancy and breastfeeding due to insufficient safety data. Mild side effects (nausea, dizziness, GI upset) occasionally reported.
Duke (2002) rates hawthorn as +++ — one of the most clinically supported cardiovascular herbs. Clinical evidence (score 2) supports its use for decreasing cardiac output (NYHA functional Stage II heart failure), as recognized by Commission E. Key activities include vasodilation, positive inotropic effects, and antioxidant protection of vascular tissue. Dose: 160–900 mg standardized leaf/flower extract (containing 18.75% oligomeric proanthocyanidins) daily. Duke emphasizes that hawthorn should not replace conventional heart failure therapy, and therapeutic effects may take 4–8 weeks to emerge. Mild interactions with cardiac glycosides (digitalis) are possible (Duke, 2002).
Fenugreek appears https://www.nccih.nih.gov/health/fenugreek for most people.
Less serious side effects like diarrhea and indigestion have been reported anecdotally. You may also experience https://pubmed.ncbi.nlm.nih.gov/26251835/, which could be harmful if you have an eating disorder or are trying to https://www.healthline.com/nutrition/how-to-gain-weight. Moreover, some people report a strange and slightly sweet body odor when supplementing, but this is unconfirmed. Given its effect on blood sugar, fenugreek should be used with caution if you’re taking diabetes medication or other supplements that lower blood sugar levels.
Duke (2002) provides strong clinical evidence (score 2) for fenugreek's hypoglycemic and hypocholesterolemic activities — among the best-evidenced herbal treatments for blood sugar and lipid management. Anti-inflammatory and demulcent activities also have clinical support. The seed is Commission E approved as an appetite stimulant. Dose: 6–50 g of ground seeds daily for blood sugar management; 1–4 g seeds in tea for digestive use. The plant has lactagogue effects and can cause maple syrup-like body odor due to sotolon content. Contraindicated in pregnancy at medicinal doses due to uterotonic effects (Duke, 2002).
External Ids
Botanical Description
Small deciduous tree or large shrub, densely thorny, with deeply lobed, glossy leaves (more deeply cut than midland hawthorn). Clusters of small, five-petalled white flowers with a strong, musky scent appear in spring ('May blossom'), followed by small red berries (haws), each containing a single seed (nutlet) - the origin of the species name monogyna.[4]
Erect annual herb with trifoliate leaves, each leaflet oblong and finely toothed toward the tip. Small, pale yellow to white, pea-like flowers are borne singly or in pairs in the leaf axils, followed by long, slender, curved seed pods.[11]
Habitat
One of the commonest hedgerow and scrub trees of Europe, growing in hedgerows, woodland edges, scrub and pasture on a wide range of soils; native to Europe, North Africa and Western Asia.[4]
Cultivated widely as a food and forage crop; native to the eastern Mediterranean and western Asia, now grown throughout South Asia, the Middle East and North Africa.[11]
Harvesting
Flowers are picked as they open in May, leaves are picked with the young flowering shoots, and the ripe red berries (haws) are gathered in autumn after the first frosts soften them slightly; all three parts are traditionally combined.[4]
Leaves and young sprouts are harvested throughout the growing season; seed pods are collected when fully mature and dried, then the hard seeds are threshed out.[11]
Traditional Uses
Common hawthorn shares the same long cardiovascular and calming tradition as midland hawthorn, used across European herbal medicine as a heart tonic for mild circulatory complaints, palpitations and nervous tension, and remains one of the most clinically studied cardiovascular botanicals.[4]
Fenugreek seed has an ancient tradition across the Mediterranean, Middle East and South Asia as a digestive and appetite-stimulant remedy and lactation aid, and modern clinical research strongly supports its traditional use for blood sugar and cholesterol management, formalised in Commission E approval as an appetite stimulant.[5, 11, 12]
Preparations
Leaf-and-flower extract standardised to flavonoid or procyanidin content, taken as tablets or capsules; the best-studied clinical form.
Ground seeds taken with food, or whole seeds soaked/simmered as a tea, the traditional preparation for digestive and blood sugar support.
Standardized seed extract in capsule form, the form most used in clinical trials on blood sugar and cholesterol.
Dosage
The EU herbal monograph on Crataegus spp., folium cum flore gives dry extracts in divided daily doses of 240-900 mg (single dose 80-450 mg) or, for one quantified extract, 570-1750 mg daily (single dose 190-350 mg), in adults and elderly. If symptoms persist longer than 2 weeks a doctor should be consulted, and hawthorn is never used as a substitute for prescribed heart medication without medical supervision. Educational reference only, not a prescription.
The EU herbal monograph gives 1-2 g of the comminuted leaf and flower in 150 mL of boiling water as an infusion, up to 4 times daily (maximum 6 g daily), in adults and elderly. Educational reference only, not a prescription.
References
Drug Class Interactions
Lookalikes Review
Pairings
Not documented
Fenugreek and bitter melon can each lower blood sugar, so taking them together — especially alongside diabetes medicines — may add up and increase the risk of hypoglycaemia. Monitor your blood glucose.[15, 16]
Fenugreek and black seed (Nigella sativa) can each lower blood sugar, so taking them together — especially alongside diabetes medicines — may add up and increase the risk of hypoglycaemia. Monitor your blood glucose.[15, 17]
References & Sources
- Ez-Zahra Amrati, F., Mssillou, I., Boukhira, S., Djiddi Bichara, M. et al (2024) 'Phenolic Composition of Crataegus monogyna Jacq. Extract and Its Anti-Inflammatory, Hepatoprotective, and Antileukemia Effects', Pharmaceuticals (Basel), 17(6), pp. 786. doi:10.3390/ph17060786 Preclinical
https://doi.org/10.3390/ph17060786 - Lis, M., Szczypka, M., Suszko-Pawłowska, A., Sokół-Łętowska, A. et al (2019) 'Hawthorn (Crataegus monogyna) Phenolic Extract Modulates Lymphocyte Subsets and Humoral Immune Response in Mice', Planta Medica, 86(2), pp. 160-168. doi:10.1055/a-1045-5437 Preclinical
https://doi.org/10.1055/a-1045-5437 - Paun, G., Neagu, E., Albu, C., Alecu, A. et al (2024) 'Antioxidant and Antidiabetic Activity of Crataegus monogyna L. and Cornus mas Fruit Extracts', Molecules, 29(15), pp. 3595. doi:10.3390/molecules29153595 Preclinical
https://doi.org/10.3390/molecules29153595 - Nabavi, S.F., Habtemariam, S., Ahmed, T., Sureda, A., Daglia, M. and Sobarzo-Sanchez, E (2015) 'Polyphenolic Composition of Crataegus monogyna Jacq.: From Chemistry to Medical Applications', Nutrients, 7(9), pp. 7708-7728. doi:10.3390/nu7095361 Meta-analysis / review
https://doi.org/10.3390/nu7095361 - Belabdelli, F., Bekhti, N., Piras, A., Benhafsa, F.M., Ilham, M. and Adil, S (2021) 'Chemical composition, antioxidant and antibacterial activity of Crataegus monogyna leaves' extracts', Natural Product Research, 36(12), pp. 3234-3239. doi:10.1080/14786419.2021.1958215 Preclinical
https://doi.org/10.1080/14786419.2021.1958215 - Jalali, A.S., Hasanzadeh, S. and Malekinejad, H (2012) 'Crataegus monogyna aqueous extract ameliorates cyclophosphamide-induced toxicity in rat testis: stereological evidences', Acta Medica Iranica, 50(1), pp. 1-8. Preclinical
https://scholar.google.com/scholar?q=Crataegus%20monogyna%20aqueous%20extract%20ameliorates%20cyclophosphamide-induced%20toxicity%20in%20rat%20testis%3A%20stereological%20evidences - Martin-Garcia, B., Razola-Diaz, M.D.C., Gomez-Caravaca, A.M., Benitez, G. and Verardo, V (2021) 'Setup of an Ultrasonic-Assisted Extraction to Obtain High Phenolic Recovery in Crataegus monogyna Leaves', Molecules, 26(15), pp. 4536. doi:10.3390/molecules26154536 Preclinical
https://doi.org/10.3390/molecules26154536 - Arslan, R., Bektas, N., Bor, Z. and Sener, E (2014) 'Evaluation of the antithrombotic effects of Crataegus monogyna and Crataegus davisii in the carrageenan-induced tail thrombosis model', Pharmaceutical Biology, 53(2), pp. 275-279. doi:10.3109/13880209.2014.914957 Preclinical
https://doi.org/10.3109/13880209.2014.914957 - Edwards, J.E., Brown, P.N., Talent, N., Dickinson, T.A. and Shipley, P.R (2012) 'A review of the chemistry of the genus Crataegus', Phytochemistry, 79, pp. 5-26. doi:10.1016/j.phytochem.2012.04.006 Meta-analysis / review
https://doi.org/10.1016/j.phytochem.2012.04.006 - Jarzycka, A., Lewinska, A., Gancarz, R. and Wilk, K.A (2013) 'Assessment of extracts of Helichrysum arenarium, Crataegus monogyna, Sambucus nigra in photoprotective UVA and UVB; photostability in cosmetic emulsions', Journal of Photochemistry and Photobiology B: Biology, 128, pp. 50-57. doi:10.1016/j.jphotobiol.2013.07.029 Preclinical
https://doi.org/10.1016/j.jphotobiol.2013.07.029 - Lucconi, G., Chlapanidas, T., Martino, E., Gaggeri, R., Perteghella, S. and Rossi, D (2013) 'Formulation of microspheres containing Crataegus monogyna Jacq. extract with free radical scavenging activity', Pharmaceutical Development and Technology, 19(1), pp. 65-72. doi:10.3109/10837450.2012.752387 Preclinical
https://doi.org/10.3109/10837450.2012.752387 - Zorniak, M., Szydlo, B. and Krzeminski, T.F (2017) 'Crataegus special extract WS 1442: up-to-date review of experimental and clinical experiences', Journal of Physiology and Pharmacology, 68(4), pp. 521-526. Meta-analysis / review
https://scholar.google.com/scholar?q=Crataegus%20special%20extract%20WS%201442%3A%20up-to-date%20review%20of%20experimental%20and%20clinical%20experiences - European Medicines Agency (2016) 'European Union herbal monograph on Crataegus spp., folium cum flore'. Traditional / reference
https://scholar.google.com/scholar?q=European%20Union%20herbal%20monograph%20on%20Crataegus%20spp.%2C%20folium%20cum%20flore - Pittler, M.H., Guo, R. and Ernst, E (2008) 'Hawthorn extract for treating chronic heart failure'. Traditional / reference
https://scholar.google.com/scholar?q=Hawthorn%20extract%20for%20treating%20chronic%20heart%20failure - Royal Botanic Gardens, Kew (n.d.). Available at: https://powo.science.kew.org Traditional / reference
https://powo.science.kew.org - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Tankanow, R., Tamer, H.R., Streetman, D.S., Smith, S.G., Welton, J.L., Annesley, T., Aaronson, K.D. and Bleske, B.E (2003) 'Interaction study between digoxin and a preparation of hawthorn (Crataegus oxyacantha)', Journal of Clinical Pharmacology, 43(6), pp. 637-642. doi:10.1177/0091270003253417 Randomized trial
https://doi.org/10.1177/0091270003253417 - Pittler, M.H., Guo, R. and Ernst, E (2008) 'Hawthorn extract for treating chronic heart failure', Cochrane Database of Systematic Reviews, 2008(1), pp. CD005312. doi:10.1002/14651858.CD005312.pub2 Meta-analysis / review
https://doi.org/10.1002/14651858.CD005312.pub2 - Pittler, M.H., Guo, R. and Ernst, E (2008) 'Hawthorn extract for treating chronic heart failure', Cochrane Database of Systematic Reviews, 2008(1), pp. CD005312. doi:10.1002/14651858.CD005312.pub2 Meta-analysis / review
https://doi.org/10.1002/14651858.CD005312.pub2 - Ghasemzadeh Rahbardar, M. and Hosseinzadeh, H (2024) 'Therapeutic potential of hypnotic herbal medicines: A comprehensive review', Phytotherapy Research, 38(6), pp. 3037-3059. doi:10.1002/ptr.8201 Meta-analysis / review
https://doi.org/10.1002/ptr.8201 - Block, K.I., Gyllenhaal, C. and Mead, M.N (2004) 'Safety and efficacy of herbal sedatives in cancer care', Integrative Cancer Therapies, 3(2), pp. 128-148. doi:10.1177/1534735404265003 Meta-analysis / review
https://doi.org/10.1177/1534735404265003
- Faghfoori, Z., Javadivala, Z., Khalili, Y. and Malek Mahdavi, A (2023) 'Effects of Trigonella foenum-graecum (fenugreek) on rheumatoid arthritis: a systematic review', Immunopharmacology and Immunotoxicology, 45(5), pp. 626-634. doi:10.1080/08923973.2023.2202298 Meta-analysis / review
https://doi.org/10.1080/08923973.2023.2202298 - Ouzir, M., El Bairi, K. and Amzazi, S (2016) 'Toxicological properties of fenugreek (Trigonella foenum graecum)', Food and Chemical Toxicology, 96, pp. 145-154. doi:10.1016/j.fct.2016.08.003 Meta-analysis / review
https://doi.org/10.1016/j.fct.2016.08.003 - Rao, A., Steels, E., Inder, W.J., Abraham, S. and others (2016) 'Testofen, a specialised Trigonella foenum-graecum seed extract reduces age-related symptoms of androgen decrease, increases testosterone levels and improves sexual function in healthy aging males in a double-blind randomised clinical study', The Aging Male, 19(2), pp. 134-142. doi:10.3109/13685538.2015.1135323 Randomized trial
https://doi.org/10.3109/13685538.2015.1135323 - Avalos-Soriano, A., De la Cruz-Cordero, R., Rosado, J.L. and Garcia-Gasca, T (2016) '4-Hydroxyisoleucine from Fenugreek (Trigonella foenum-graecum): Effects on Insulin Resistance Associated with Obesity', Molecules, 21(11), pp. 1596. doi:10.3390/molecules21111596 Preclinical
https://doi.org/10.3390/molecules21111596 - Neelakantan, N., Narayanan, M., de Souza, R.J. and van Dam, R.M (2014) 'Effect of fenugreek (Trigonella foenum-graecum L.) intake on glycemia: a meta-analysis of clinical trials', pp. 7. Meta-analysis / review
https://scholar.google.com/scholar?q=Effect%20of%20fenugreek%20%28Trigonella%20foenum-graecum%20L.%29%20intake%20on%20glycemia%3A%20a%20meta-analysis%20of%20clinical%20trials - Nagulapalli Venkata, K.C., Swaroop, A., Bagchi, D. and Bishayee, A (2017) 'A small plant with big benefits: Fenugreek (Trigonella foenum-graecum Linn.) for disease prevention and health promotion', Molecular Nutrition & Food Research, 61(6), pp. 1600950. doi:10.1002/mnfr.201600950 Meta-analysis / review
https://doi.org/10.1002/mnfr.201600950 - Ulbricht, C., Basch, E., Burke, D., Cheung, L. and others (2007) 'Fenugreek (Trigonella foenum-graecum L. Leguminosae): an evidence-based systematic review by the natural standard research collaboration', Journal of Herbal Pharmacotherapy, 7(3-4), pp. 143-177. doi:10.1080/15228940802142852 Meta-analysis / review
https://doi.org/10.1080/15228940802142852 - El Bairi, K., Ouzir, M., Agnieszka, N. and Khalki, L (2017) 'Anticancer potential of Trigonella foenum graecum: Cellular and molecular targets', Biomedicine & Pharmacotherapy, 90, pp. 479-491. doi:10.1016/j.biopha.2017.03.071 Meta-analysis / review
https://doi.org/10.1016/j.biopha.2017.03.071 - Piao, C.H., Bui, T.T., Song, C.H., Shin, H.S. and others (2017) 'Trigonella foenum-graecum alleviates airway inflammation of allergic asthma in ovalbumin-induced mouse model', Biochemical and Biophysical Research Communications, 482(4), pp. 1284-1288. doi:10.1016/j.bbrc.2016.12.029 Preclinical
https://doi.org/10.1016/j.bbrc.2016.12.029 - Asif, M., Yousaf, H.M., Saleem, M., Saadullah, M. and others (2021) 'Trigonella foenum-graecum Seeds Oil Attenuated Inflammation and Angiogenesis in vivo through Down-Regulation of TNF-alpha', Anti-Cancer Agents in Medicinal Chemistry, 21(11), pp. 1460-1471. doi:10.2174/1871520620666201005100132 Preclinical
https://doi.org/10.2174/1871520620666201005100132 - World Health Organization (1999) 'WHO Monographs on Selected Medicinal Plants'. Traditional / reference
https://scholar.google.com/scholar?q=WHO%20Monographs%20on%20Selected%20Medicinal%20Plants - Kumar, P. and Bhandari, U (2013) 'Protective effect of fenugreek (Trigonella foenum-graecum L.) seeds in experimentally-induced myocardial infarction', 23(2), pp. 255--261. Traditional / reference
https://scholar.google.com/scholar?q=Protective%20effect%20of%20fenugreek%20%28Trigonella%20foenum-graecum%20L.%29%20seeds%20in%20experimentally-induced%20myocardial%20infarction - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Neelakantan, N., Narayanan, M., de Souza, R.J. and van Dam, R.M (2014) 'Effect of fenugreek (Trigonella foenum-graecum L.) intake on glycemia: a meta-analysis of clinical trials', Nutrition Journal, 13, pp. 7. doi:10.1186/1475-2891-13-7 Meta-analysis / review
https://doi.org/10.1186/1475-2891-13-7 - Kim, J., Noh, W., Kim, A., Choi, Y. and Kim, Y.S (2023) 'The effect of fenugreek in type 2 diabetes and prediabetes: a systematic review and meta-analysis of randomized controlled trials', International Journal of Molecular Sciences, 24(18), pp. 13999. doi:10.3390/ijms241813999 Meta-analysis / review
https://doi.org/10.3390/ijms241813999 - Zhang, X., Zhao, Y., Song, Y. and Miao, M (2024) 'Effects of Momordica charantia L. supplementation on glycemic control and lipid profile in type 2 diabetes mellitus patients: a systematic review and meta-analysis of randomized controlled trials', Heliyon, 10(10), pp. e31126. doi:10.1016/j.heliyon.2024.e31126 Meta-analysis / review
https://doi.org/10.1016/j.heliyon.2024.e31126 - Daryabeygi-Khotbehsara, R., Golzarand, M., Ghaffari, M.P. and Djafarian, K (2017) 'Nigella sativa improves glucose homeostasis and serum lipids in type 2 diabetes: a systematic review and meta-analysis', Complementary Therapies in Medicine, 35, pp. 6-13. doi:10.1016/j.ctim.2017.08.016 Meta-analysis / review
https://doi.org/10.1016/j.ctim.2017.08.016
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.